🇺🇸 FDA
Patent

US 11225477

Inhibitors of influenza virus replication, application methods and uses thereof

granted A61KA61K31/506A61K31/517

Quick answer

US patent 11225477 (Inhibitors of influenza virus replication, application methods and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/506, A61K31/517, A61K31/519, A61K31/52